Patents Represented by Attorney, Agent or Law Firm Robert L. Starnes
  • Patent number: 7666630
    Abstract: The present invention relates to isolated polypeptides having lipase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: September 30, 2005
    Date of Patent: February 23, 2010
    Assignee: Novozymes, Inc.
    Inventors: Debbie Yaver, Suzanne Otani, Haiyan Ge, Janine Lin, Chritopher Amolo, Kim Borch, Shamkant Anant Patkar, Michael Lamsa, Barbara Cherry
  • Patent number: 7666625
    Abstract: The present invention relates to methods of producing a heterologous biological substance, comprising: (a) cultivating a mutant of a parent Bacillus cell under conditions conducive for the production of the heterologous biological substance, wherein (i) the mutant cell comprises a first nucleic acid sequence directing synthesis of the heterologous biological substance and a second nucleic acid sequence comprising a modification of at least one of the genes cypX and yvmC, which are involved in the production of a red pigment, and (ii) the mutant cell is deficient in the production of the red pigment compared to the parent Bacillus cell when cultivated under the same conditions; and (b) recovering the heterologous biological substance from the cultivation medium. The present invention also relates to mutants of Bacillus cells and methods for producing the mutants.
    Type: Grant
    Filed: December 9, 2008
    Date of Patent: February 23, 2010
    Assignee: Novozymes, Inc.
    Inventors: Maria Tang, Alan Sloma, David Sternberg, Linda Sternberg, legal representative, Regine Behr
  • Patent number: 7638616
    Abstract: The present invention relates to variants of a parent beta-glucosidase, comprising a substitution at one or more positions corresponding to positions 142, 183, 266, and 703 of amino acids 1 to 842 of SEQ ID NO: 2 or corresponding to positions 142, 183, 266, and 705 of amino acids 1 to 844 of SEQ ID NO: 70, wherein the variant has beta-glucosidase activity. The present invention also relates to nucleotide sequences encoding the variant beta-glucosidases and to nucleic acid constructs, vectors, and host cells comprising the nucleotide sequences.
    Type: Grant
    Filed: June 26, 2008
    Date of Patent: December 29, 2009
    Assignee: Novozymes, Inc.
    Inventors: Ana Fidantsef, Michael Lamsa, Brian Gorre-Clancy
  • Patent number: 7608689
    Abstract: The present invention relates to methods for degrading or converting a cellulosic material and for producing a substance from a cellulosic material.
    Type: Grant
    Filed: September 29, 2006
    Date of Patent: October 27, 2009
    Assignee: Novozymes, Inc.
    Inventors: Paul Harris, Michael Rey, Hanshu Ding
  • Patent number: 7534594
    Abstract: The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated nucleic acids encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acids as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: August 8, 2007
    Date of Patent: May 19, 2009
    Assignee: Novozymes, Inc.
    Inventors: William D. Dotson, Jennifer Greenier, Hanshu Ding
  • Patent number: 7494798
    Abstract: The present invention relates to an isolated polynucleotide of the complete chromosome of Bacillus licheniformis. The present invention also relates to isolated genes of the chromosome of Bacillus licheniformis which encode biologically active substances and to nucleic acid constructs, vectors, and host cells comprising the genes as well as methods for producing biologically active substances encoded by the genes and to methods of using the isolated genes of the complete chromosome of Bacillus licheniformis.
    Type: Grant
    Filed: November 5, 2004
    Date of Patent: February 24, 2009
    Assignee: Novozymes, Inc.
    Inventors: Randy Berka, Michael Rey, Preethi Ramaiya, Jens Tønne Andersen, Michael Dolberg Rasmussen, Peter Bjarke Olsen
  • Patent number: 7476516
    Abstract: The present invention relates to methods of producing a heterologous biological substance, comprising: (a) cultivating a mutant of a parent Bacillus cell under conditions conducive for the production of the heterologous biological substance, wherein (i) the mutant cell comprises a first nucleic acid sequence directing synthesis of the heterologous biological substance and a second nucleic acid sequence comprising a modification of at least one of the genes cypX and yvmC, which are involved in the production of a red pigment, and (ii) the mutant cell is deficient in the production of the red pigment compared to the parent Bacillus cell when cultivated under the same conditions; and (b) recovering the heterologous biological substance from the cultivation medium. The present invention also relates to mutants of Bacillus cells and methods for producing the mutants.
    Type: Grant
    Filed: July 25, 2003
    Date of Patent: January 13, 2009
    Assignee: Novozymes, Inc.
    Inventors: Maria Tang, Alan Sloma, David Sternberg, Regine Behr
  • Patent number: 7413888
    Abstract: The present invention relates to variants of a parent beta-glucosidase, comprising a substitution at one or more positions corresponding to positions 142, 183, 266, and 703 of amino acids 1 to 842 of SEQ ID NO: 2 or corresponding to positions 142, 183, 266, and 705 of amino acids 1 to 844 of SEQ ID NO: 70, wherein the variant has beta-glucosidase activity. The present invention also relates to nucleotide sequences encoding the variant beta-glucosidases and to nucleic acid constructs, vectors, and host cells comprising the nucleotide sequences.
    Type: Grant
    Filed: April 30, 2004
    Date of Patent: August 19, 2008
    Assignee: Novozymes, Inc.
    Inventors: Ana Fidantsef, Michael Lamsa, Brian Gorre Clancy
  • Patent number: 7393664
    Abstract: The present invention relates to methods for producing a polypeptide, comprising: (a) cultivating a fungal host cell in a medium conducive for the production of the polypeptide, wherein the fungal host cell comprises a nucleic acid construct comprising a first nucleotide sequence encoding a signal peptide operably linked to a second nucleotide sequence encoding the polypeptide, wherein the first nucleotide sequence is foreign to the second nucleotide sequence and the 3? end of the first nucleotide sequence is immediately upstream of the initiator codon of the second nucleotide sequence. The present invention also relates to the isolated signal peptide sequences and to constructs, vectors, and fungal host cells comprising the signal peptide sequences operably linked to nucleotide sequences encoding polypeptides.
    Type: Grant
    Filed: April 30, 2004
    Date of Patent: July 1, 2008
    Assignee: Novozymes, Inc.
    Inventors: Suchindra Maiyuran, Ana Fidantsef, Howard Brody
  • Patent number: 7368271
    Abstract: The present invention relates to isolated polypeptides having alpha-glucosidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: July 6, 2005
    Date of Patent: May 6, 2008
    Assignee: Novozymes, Inc.
    Inventors: Debbie Yaver, Janine Lin, Alexander Blinkovsky, Kimberly Brown, Michael Rey
  • Patent number: 7368262
    Abstract: The present invention relates to methods for producing a biological substance, comprising: (a) cultivating a fungal host cell in a medium conducive for the production of the biological substance, wherein the fungal host cell comprises a first nucleic acid sequence encoding the biological substance operably linked to a second nucleic acid sequence comprising a promoter variant selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, and SEQ ID NO: 12; and a subsequence thereof; and hybrid and tandem promoters thereof; and (b) isolating the biological substance from the cultivation medium. The present invention also relates to the isolated promoter variants and to constructs, vectors, and fungal host cells comprising the promoter variants operably linked to nucleic acid sequences encoding biological substances.
    Type: Grant
    Filed: November 18, 2003
    Date of Patent: May 6, 2008
    Assignee: Novozymes, Inc.
    Inventors: Debbie Yaver, Peter Nham
  • Patent number: 7361495
    Abstract: The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: January 28, 2005
    Date of Patent: April 22, 2008
    Assignee: Novozymes, Inc.
    Inventors: Kimberly Brown, Paul Harris, Elizabeth Zaretsky, Edward Re, Elena Vlasenko, Keith McFarland, Alfredo Lopez de Leon
  • Patent number: 7354743
    Abstract: The present invention relates to methods for degrading a lignocellulosic material, comprising: treating the lignocellulosic material with an effective amount of one or more cellulolytic enzymes in the presence of at least one surfactant selected from the group consisting of a secondary alcohol ethoxylate, fatty alcohol ethoxylate, nonylphenol ethoxylate, tridecyl ethoxylate, and polyoxyethylene ether, wherein the presence of the surfactant increases the degradation of lignocellulosic material compared to the absence of the surfactant.
    Type: Grant
    Filed: January 14, 2005
    Date of Patent: April 8, 2008
    Assignee: Novozymes, Inc.
    Inventors: Elena Vlasenko, Joel Cherry, Feng Xu
  • Patent number: 7332341
    Abstract: The present invention relates to mutants cells comprising a marker-free modification of a gene, and methods for obtaining and using such mutant cells.
    Type: Grant
    Filed: March 31, 2005
    Date of Patent: February 19, 2008
    Assignee: Novozymes, Inc.
    Inventors: John C. Royer, Lynne M. Christanson, Gregory A. Gambetta, Howard Brody, Suzanne M. Otani, Wendy T. Yoder
  • Patent number: 7303877
    Abstract: The present invention relates to methods of producing a heterologous biological substance, comprising: (a) cultivating a mutant of a parent Aspergillus niger strain in a medium suitable for the production of the heterologous biological substance, wherein (i) the mutant strain comprises a first nucleotide sequence encoding the heterologous biological substance and one or more second nucleotide sequences comprising a modification of glaA and at least one of the genes selected from the group consisting of asa, amyA, amyB, prtT, and oah, and (ii) the mutant strain is deficient in the production of glucoamylase and at least one enzyme selected from the group consisting of acid stable alpha-amylase, neutral alpha-amylase A, and neutral alpha-amylase B, protease, and oxalic acid hydrolase compared to the parent Aspergillus niger strain when cultivated under identical conditions; and (b) recovering the heterologous biological substance from the cultivation medium.
    Type: Grant
    Filed: March 31, 2004
    Date of Patent: December 4, 2007
    Assignee: Novozymes, Inc.
    Inventors: Mariah Connelly, Howard Brody
  • Patent number: 7279308
    Abstract: The present invention relates to isolated polypeptides having aminopeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: June 30, 2004
    Date of Patent: October 9, 2007
    Assignee: Novozymes, Inc.
    Inventors: Alexander Blinkovsky, Kimberly Brown, Elizabeth Golightly, Tony Byun, Lene V. Kofed
  • Patent number: 7271244
    Abstract: The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated nucleic acids encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acids as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: February 4, 2005
    Date of Patent: September 18, 2007
    Assignee: Novozymes, Inc.
    Inventors: William D. Dotson, Jennifer Greenier, Hanshu Ding
  • Patent number: 7244605
    Abstract: The present invention relates to isolated polypeptides having beta-glucosidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: October 28, 2004
    Date of Patent: July 17, 2007
    Assignee: Novozymes, Inc.
    Inventors: Paul Harris, Elizabeth Golightly
  • Patent number: 7220565
    Abstract: The present invention relates to isolated polypeptides having cellobiohydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: January 6, 2006
    Date of Patent: May 22, 2007
    Assignee: Novozymes, Inc.
    Inventors: Kimberly Brown, Paul Harris, Alfredo Lopez De Leon, Sandra Merino
  • Patent number: 7198938
    Abstract: The present invention relates to methods of obtaining a mutant cell from a filamentous fungal parent cell, comprising: (a) obtaining mutant cells of the parent cell; (b) identifying the mutant cell which exhibits a more restricted colonial phenotype and/or a more extensive hyphal branching than the parent cell; and (c) identifying the mutant cell which has an improved property for production of a heterologous polypeptide than the parent cell, when the mutant and parent cells are cultured under the same conditions.
    Type: Grant
    Filed: June 30, 2004
    Date of Patent: April 3, 2007
    Assignee: Novozymes, Inc.
    Inventors: Jeffrey R. Shuster, John C. Royer